Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: A phase II Southwest Oncology Group Study (S0415)

Por Gold, Philip J., Goldman, Bryan, Iqbal, Syma, Leichman, Lawrence P., Zhang, Wu, Lenz, Heinz-Josef, Blanke, Charles D.
Publicado em 2010

Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center

Por Bitterman, Danielle S., Grew, David, Gu, Ping, Cohen, Richard F., Sanfilippo, Nicholas J., Leichman, Cynthia G., Leichman, Lawrence P., Moore, Harvey G., Gold, Heather T., Du, Kevin L.
Publicado no J Gastrointest Oncol (2015)

S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarc...

Por Leichman, Lawrence P., Goldman, Bryan H., Bohanes, Pierre O., Lenz, Heinz J., Thomas, Charles R., Billingsley, Kevin G., Corless, Christopher L., Iqbal, Syma, Gold, Philip J., Benedetti, Jacqueline K., Danenberg, Kathleen D., Blanke, Charles D.
Publicado em 2011